Docosahexaenoic Acid
DHA is the most abundant omega-3 in the brain and retina, and the omega-3 with the strongest evidence base in pregnancy and lactation. ≥200 mg/day during pregnancy supports fetal brain and eye development, and Cochrane shows ≥500 mg/day combined EPA+DHA reduces preterm birth. Outside pregnancy, the evidence is mixed: DHA-only formulas underperform EPA-predominant ones for depression, and DHA failed to slow Alzheimer's progression in a large RCT.
Quick decision guide
May help most
Pregnant and lactating women not regularly eating fatty fish; adults with low dietary DHA intake; vegetarians and vegans (algae-derived); people with macular degeneration risk who want a vision-protection adjunct.
Common dosing range
General: 250–500 mg/day combined EPA+DHA. Pregnancy/lactation: at least 200–300 mg/day DHA on top of baseline. Cognitive support in early age-related decline: 900 mg/day algal DHA in MIDAS trial.
When to expect effects
Plasma DHA shifts in weeks; pregnancy outcomes measured over months; cognitive and visual endpoints over 4–6 months.
Watch out for
Don't take DHA-only formulas for depression — EPA-predominant blends have the evidence. Don't expect DHA to slow established Alzheimer's — RCT was null.
Evidence snapshot
What is it
Is it worth it for you?
Use this as a quick fit check, not a diagnosis.
Worth considering if…
Probably skip if…
Evidence at a glance
| Goal | Effect | Best fit | Time |
|---|---|---|---|
Pregnancy: fetal brain and retinal development Strong Evidence | Reliably raises maternal and infant DHA status; modest, inconsistent improvements on offspring neurodevelopmental endpoints | Pregnant women not eating 2+ servings of low-mercury fatty fish per week | Fetal tissue accumulation through third trimester; postnatal endpoints measured at 4–7 years in long-term cohorts |
Pregnancy: preterm birth prevention (EPA+DHA combo) Strong Evidence | 11% relative reduction in preterm birth <37 wk and 42% reduction <34 wk at ≥500 mg/day EPA+DHA in pregnancy | Pregnant women, especially those with prior preterm birth or low baseline omega-3 intake | Pregnancy endpoint at delivery; supplementation started in second trimester showed largest effect |
Age-related cognitive decline (early-stage) Limited Evidence | Modest improvement in learning/episodic memory at 900 mg/day algal DHA over 24 weeks in early decline | Adults 55+ with subjective or mild objective age-related cognitive decline, NOT established dementia | 24 weeks in MIDAS |
Reading performance in underperforming children Limited Evidence | Modest improvement in reading age in children below 20th percentile; no effect in higher-performing children | Children with documented reading difficulties and possibly low DHA intake | 16 weeks in Oxford-AHA |
Depression (DHA-predominant formulas) Mixed Evidence | DHA-predominant formulas: no significant antidepressant effect vs placebo (Liao 2019 meta-analysis) | Not appropriate for depression — switch to EPA-predominant blend | Not established for DHA-only in depression |
Pregnancy: fetal brain and retinal development
- Effect
- Reliably raises maternal and infant DHA status; modest, inconsistent improvements on offspring neurodevelopmental endpoints
- Best fit
- Pregnant women not eating 2+ servings of low-mercury fatty fish per week
- Time
- Fetal tissue accumulation through third trimester; postnatal endpoints measured at 4–7 years in long-term cohorts
Pregnancy: preterm birth prevention (EPA+DHA combo)
- Effect
- 11% relative reduction in preterm birth <37 wk and 42% reduction <34 wk at ≥500 mg/day EPA+DHA in pregnancy
- Best fit
- Pregnant women, especially those with prior preterm birth or low baseline omega-3 intake
- Time
- Pregnancy endpoint at delivery; supplementation started in second trimester showed largest effect
Age-related cognitive decline (early-stage)
- Effect
- Modest improvement in learning/episodic memory at 900 mg/day algal DHA over 24 weeks in early decline
- Best fit
- Adults 55+ with subjective or mild objective age-related cognitive decline, NOT established dementia
- Time
- 24 weeks in MIDAS
Reading performance in underperforming children
- Effect
- Modest improvement in reading age in children below 20th percentile; no effect in higher-performing children
- Best fit
- Children with documented reading difficulties and possibly low DHA intake
- Time
- 16 weeks in Oxford-AHA
Depression (DHA-predominant formulas)
- Effect
- DHA-predominant formulas: no significant antidepressant effect vs placebo (Liao 2019 meta-analysis)
- Best fit
- Not appropriate for depression — switch to EPA-predominant blend
- Time
- Not established for DHA-only in depression
Evidence for 5 uses
AI-assisted evidence assessment — talk to your doctor before relying on any single supplement.
Pregnancy: fetal brain and retinal development
Corrects deficiencyDHA accumulates rapidly in fetal brain and retina during the third trimester and continues through the first two postnatal years. Maternal DHA intake correlates with maternal-to-infant transfer and with infant tissue DHA status. Pregnant women not regularly eating fish are advised to supplement at least 200–300 mg/day DHA. The neurodevelopmental endpoints in offspring of supplemented mothers — visual acuity, executive function, IQ at 4–7 years — are inconsistently positive across trials, but the biological case is strong and the safety record is excellent.
Bottom line: Strong basis for ≥200 mg/day DHA in pregnancy and lactation when fish intake is inadequate. The 'no harm if uncertain benefit' case is solid.
Pregnancy: preterm birth prevention (EPA+DHA combo)
Supplement benefitThe 2018 Cochrane review of 70 RCTs (n=19,927 women) found high-quality evidence that omega-3 LCPUFA supplementation in pregnancy reduces preterm birth before 37 weeks (RR 0.89) and substantially reduces very preterm birth before 34 weeks (RR 0.58). Effect is concentrated in trials providing at least 500 mg/day combined EPA+DHA. DHA contributes; the trials used combined products. Cochrane evidence is rated high quality — this is one of the most robust omega-3 outcome findings.
Bottom line: One of the strongest omega-3 indications. Get at least 500 mg/day EPA+DHA in pregnancy from second trimester onward.
Age-related cognitive decline (early-stage)
Supplement benefitThe MIDAS trial (n=485, healthy adults 55+ with age-related cognitive decline) found 24 weeks of 900 mg/day algal DHA improved learning and episodic memory vs placebo on the Paired Associate Learning test. Effect size was clinically modest but real in this population. The 'early decline / pre-dementia' window appears to be where DHA may help most — by the time established Alzheimer's is present, the large ADCS DHA RCT showed NO benefit. Sequential interpretation: maintain DHA status early; don't expect rescue late.
Bottom line: Reasonable for adults 55+ with early subjective cognitive change. Don't use after Alzheimer's diagnosis — the evidence is negative.
Evidence is mixed
MIDAS (positive, early-decline healthy older adults) and the ADCS DHA trial (negative, established Alzheimer's) reached opposite conclusions in different populations. Read together they suggest DHA may help maintain cognition early but cannot rescue established disease.
Reading performance in underperforming children
Supplement benefitThe Oxford-AHA DHA trial (Richardson et al., 2012) randomized 362 UK primary-school children with below-average reading to 600 mg/day algal DHA or placebo for 16 weeks. The overall cohort showed no significant effect. However, in the prespecified subgroup of the lowest-performing readers (below the 20th percentile), DHA produced a clinically meaningful improvement in reading performance. The subgroup finding has not been definitively replicated in subsequent trials.
Bottom line: Subgroup-only signal in poor readers; not a substitute for reading instruction support. Worth trying as a low-risk adjunct.
Depression (DHA-predominant formulas)
Disease adjunctMeta-analyses of omega-3 for depression consistently find benefit ONLY when EPA is the predominant fraction (≥60% EPA). DHA-predominant formulas have not been significantly different from placebo. If depression is your goal, pick an EPA-predominant fish oil at 1–2 g/day EPA — not a DHA-rich product. This is one of the clearest 'form matters' findings in the omega-3 literature.
Bottom line: Wrong omega-3 for depression. Switch to an EPA-predominant product at 1–2 g/day EPA.
How it works
How to take it
What to track
Bottom line: Target 250 mg/day combined EPA+DHA as a baseline; ≥200 mg/day DHA in pregnancy and lactation; 900 mg/day algal DHA if trying for early-cognitive-decline benefit. Take with fat. Don't pick DHA-only for depression — EPA-predominant is the right choice there.
5 commercial forms
Compare the main delivery options and what they’re best suited for.
Algae-derived DHA
Pregnancy / veganDHA produced from cultivated microalgae — the original source organisms that fish accumulate DHA from by eating. Vegan-friendly, fully sustainable, naturally mercury-free. The form used in essentially all infant formula DHA fortification and in the MIDAS cognitive trial. Per-gram cost is higher than fish oil but the purity profile is superior for pregnancy and pediatric use.
Comparable absorption to fish-derived DHA; preferred for pregnancy, vegan, fish-allergic.
Fish oil — triglyceride form (rTG or nTG)
StandardDHA + EPA in triglyceride form, the form found in whole fish. Slightly better absorbed than ethyl-ester products. Most premium third-party-tested fish oils use this form. DHA content is typically 30–50% of total omega-3 in mixed fish oil products.
Slightly better absorption than ethyl ester; the form in whole fish.
Fish oil — ethyl ester (EE)
AffordableConcentrated DHA + EPA as ethyl esters. Most affordable per gram of omega-3. Absorption is somewhat lower than TG forms on an empty stomach but largely equivalent with a fatty meal. The form of prescription Lovaza.
Lower absorption on empty stomach; equivalent with food.
Krill oil
Phospholipid-boundDHA + EPA bound to phospholipids rather than triglycerides. Some pharmacokinetic absorption advantage in studies; per-capsule omega-3 dose is much lower (50–150 mg) than fish oil. DHA content is typically modest per capsule.
Phospholipid binding; small per-capsule dose limits practical use for high-dose DHA.
Cod liver oil
Avoid for high-doseContains DHA + EPA plus high vitamin A and D. Therapeutic DHA doses would deliver hypervitaminosis A. Not appropriate as the primary DHA source if dosing ≥1 g/day combined omega-3.
Standard fish-oil absorption but limited by accompanying high A+D content.
Safety
Know the common side effects, key cautions, and who should avoid it.
Common side effects
Serious risks
Atrial fibrillation at doses ≥3 g/day total omega-3 (combined EPA+DHA). Several large RCTs and meta-analyses identified this signal; lower DHA-only doses (200–900 mg/day) have not shown this signal.
Increased bleeding risk at high doses: DHA inhibits platelet aggregation modestly. Generally clinically minor but compounds with anticoagulants and antiplatelets. Stop ≥1 week before elective surgery if dose is ≥2 g/day combined.
Mercury contamination in cheap fish-oil products: most reputable fish oil is molecularly distilled and tests below FDA limits, but algae-derived DHA is naturally mercury-free if mercury exposure is a specific concern (pregnancy, young children).
Slight LDL-C increase: long-chain omega-3 supplementation slightly raises LDL-C (~1.5 mg/dL); clinically minor for most.
Who should avoid it
- Adults with atrial fibrillation history — keep total omega-3 below 2 g/day combined and discuss with cardiology.
- Patients on warfarin at high omega-3 doses — INR monitoring is recommended when dose changes substantially.
- Pre-surgical patients — stop omega-3 ≥1 week before elective surgery to reduce bleeding risk.
- People with fish or shellfish allergy — choose algae-derived DHA instead.
Pregnancy & breastfeeding
DHA in pregnancy is recommended, not just safe. Target ≥200–300 mg/day DHA. Algae-derived DHA is the preferred form for pregnancy because it's naturally mercury-free. Avoid high-mercury fish (shark, swordfish, king mackerel, tilefish); salmon, sardines, anchovies, and herring are good food sources. Total combined EPA+DHA up to 2 g/day is considered safe in pregnancy; don't exceed 3 g/day without obstetric guidance.
Bottom line: DHA is one of the best-tolerated supplements at typical doses. Pregnancy and lactation are positive indications, not cautions. Watch for AF at doses ≥3 g/day combined omega-3.
Interactions
DHA at high doses (≥2 g/day combined) potentiates warfarin's anticoagulant effect modestly; INR monitoring is reasonable when starting/stopping or changing dose substantially.
Additive antiplatelet effect at high omega-3 doses. Clinical significance is modest at typical doses (≤1 g/day DHA) but worth noting at ≥2 g/day combined.
Omega-3 (EPA+DHA) lowers BP modestly (~3–5 mmHg systolic) at high doses. Compounds with antihypertensives; monitor for orthostatic symptoms.
Fat-absorption blocker reduces DHA uptake. Take DHA at least 2 hours apart from orlistat.
Protocols featuring Docosahexaenoic Acid
Evidence-backed routines where Docosahexaenoic Acid plays a role.
Kids Daily Foundation
kids
Most children who eat a varied diet don''t need much supplementation — adequate food covers their needs. The exceptions: vitamin D (most children are deficient, especially in winter and in formula-fed infants beyond breastfeeding), omega-3 DHA (especially relevant for kids who don''t eat fatty fish 2-3× weekly), and sometimes iron (especially in vegetarian, low-meat, or picky-eating children). This protocol covers those four foundational gaps. CRITICAL FRAMING FOR PARENTS: - This is a CHILD-specific protocol. Adult doses are inappropriate and potentially harmful for kids. - ALWAYS consult your pediatrician before starting ANY supplement in children, especially infants and toddlers. - Iron supplementation should ONLY be done if ferritin is confirmed low — accidental iron overdose is the leading cause of fatal poisoning in young children. - Keep ALL supplements in child-resistant containers, out of reach. - Pediatric dosing is age and weight-dependent; doses below are general adult-recommended starting points and may need adjustment.
Teen Athlete Foundation
kids
Teen athletes (high school sports, club teams, intensive training) have specific nutritional demands during growth + heavy training. The most-common gaps: iron (especially in female athletes — menstrual losses plus training losses), magnesium (under-consumed at all ages), omega-3 DHA (kids who don''t eat fish), and adequate vitamin D. This protocol covers those evidence-backed gaps. Creatine is included with a clear caveat — the safety data in adolescents is reassuring for ages 14+ when used appropriately, but it requires honest parent + athlete + coach + pediatrician conversation. CRITICAL FRAMING: - Teen sports nutrition is mostly about FOOD, not supplements. Adequate calories (often UNDER-consumed by young athletes), protein, carbs around training, hydration, and sleep all matter more than the supplement stack. - This protocol is for ages 14-18 (older adolescents). Younger children with intensive training should be evaluated by pediatric sports medicine. - NEVER use adult pre-workout, fat-burner, or testosterone-boosting products in teens. These are explicitly inappropriate and sometimes dangerous. - Coordinate ALL supplementation with the teen''s pediatrician, especially during growth spurts.
Food sources
| Food | Amount | %DV |
|---|---|---|
| Salmon, Atlantic farmed, cooked | 3 oz (~1,240 mg DHA+EPA, ~860 mg DHA) | — |
| Salmon, Atlantic wild, cooked | 3 oz (~1,220 mg DHA+EPA, ~770 mg DHA) | — |
| Herring, Atlantic, cooked | 3 oz (~1,710 mg DHA+EPA, ~940 mg DHA) | — |
| Sardines, canned in oil, drained | 3 oz (~840 mg DHA+EPA, ~500 mg DHA) | — |
| Mackerel, Atlantic, cooked | 3 oz (~1,020 mg DHA+EPA, ~590 mg DHA) | — |
| Anchovies, canned in oil, drained | 1 oz (~590 mg DHA+EPA, ~300 mg DHA) | — |
| Trout, rainbow farmed, cooked | 3 oz (~980 mg DHA+EPA, ~580 mg DHA) | — |
| Tuna, light, canned in water | 3 oz (~170 mg DHA+EPA, ~150 mg DHA) | — |
| Tuna, white (albacore), canned in water | 3 oz (~730 mg DHA+EPA, ~535 mg DHA) | — |
| Algal oil supplement | Per softgel (~100–500 mg DHA depending on product) | — |
| Salmon roe (ikura) | 1 oz (~600 mg DHA) | — |
| Egg, DHA-fortified | 1 large egg (~75–150 mg DHA depending on brand) | — |
| Flaxseed oil (ALA, not DHA) | 1 Tbsp (~7,260 mg ALA — converts to <1% DHA in humans) | — |
| Chia seeds (ALA, not DHA) | 1 oz (~5,060 mg ALA — converts to <1% DHA in humans) | — |
Salmon, Atlantic farmed, cooked
- Amount
- 3 oz (~1,240 mg DHA+EPA, ~860 mg DHA)
- %DV
- —
Salmon, Atlantic wild, cooked
- Amount
- 3 oz (~1,220 mg DHA+EPA, ~770 mg DHA)
- %DV
- —
Herring, Atlantic, cooked
- Amount
- 3 oz (~1,710 mg DHA+EPA, ~940 mg DHA)
- %DV
- —
Sardines, canned in oil, drained
- Amount
- 3 oz (~840 mg DHA+EPA, ~500 mg DHA)
- %DV
- —
Mackerel, Atlantic, cooked
- Amount
- 3 oz (~1,020 mg DHA+EPA, ~590 mg DHA)
- %DV
- —
Anchovies, canned in oil, drained
- Amount
- 1 oz (~590 mg DHA+EPA, ~300 mg DHA)
- %DV
- —
Trout, rainbow farmed, cooked
- Amount
- 3 oz (~980 mg DHA+EPA, ~580 mg DHA)
- %DV
- —
Tuna, light, canned in water
- Amount
- 3 oz (~170 mg DHA+EPA, ~150 mg DHA)
- %DV
- —
Tuna, white (albacore), canned in water
- Amount
- 3 oz (~730 mg DHA+EPA, ~535 mg DHA)
- %DV
- —
Algal oil supplement
- Amount
- Per softgel (~100–500 mg DHA depending on product)
- %DV
- —
Salmon roe (ikura)
- Amount
- 1 oz (~600 mg DHA)
- %DV
- —
Egg, DHA-fortified
- Amount
- 1 large egg (~75–150 mg DHA depending on brand)
- %DV
- —
Flaxseed oil (ALA, not DHA)
- Amount
- 1 Tbsp (~7,260 mg ALA — converts to <1% DHA in humans)
- %DV
- —
Chia seeds (ALA, not DHA)
- Amount
- 1 oz (~5,060 mg ALA — converts to <1% DHA in humans)
- %DV
- —
Choosing a product
What to look for on the label — and what to be skeptical of.
Look for…
Be skeptical of…
Frequently asked questions
Should pregnant women take DHA?⌄
Most guidelines recommend at least 200 mg DHA/day during pregnancy and lactation.
Is algae DHA as good as fish oil?⌄
Yes, equivalent at the same DHA dose; lower contaminant risk and vegan-friendly.
References by claim
Safety
NIH Office of Dietary Supplements — Omega-3 Fatty Acids — Health Professional Fact Sheet (2024) link
Pregnancy: fetal brain and retinal development
Pregnancy: preterm birth prevention (EPA+DHA combo)
Middleton et al., 2018 (Cochrane) — PubMed — Cochrane Database of Systematic Reviews (2018) link
Age-related cognitive decline (early-stage)
Reading performance in underperforming children
Richardson et al., 2012 (DHA Oxford-AHA) — PubMed — PLOS ONE (2012) link
Depression (DHA-predominant formulas)
Liao et al., 2019 — PubMed — Translational Psychiatry (2019) link
Track Docosahexaenoic Acid with Pilora
Set up dose reminders, check interactions, and join the community in the Pilora iPhone app.
Coming to App StoreDisclaimer: These statements have not been evaluated by the FDA. This page is educational, not a substitute for personalized medical advice. Evidence grades are AI-assisted assessments — talk to your doctor before starting any new supplement, especially if you’re pregnant, breastfeeding, on medications, or managing a chronic condition.